Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Roger's 1998 Short Picks -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (5537)	3/25/1998 9:15:00 PM
From: Dauntless	Read Replies (3) \| Respond to of 18691

Asshole Wexler caught lying again. After dozens of posts claiming that Zonagen's patent was false, fraudulent, misleading, unfounded, etc. the US Patent Office today granted Zonagen the patent for Vasomax. Fred Lowrey was an EMPLOYEE of Zonagen - here's a summary. United States Patent 5,731,339 Lowrey Mar. 24, 1998 Methods and formulations for modulating the human sexual response Inventors: Lowrey; Fred (Lincoln, NE). Assignee: Zonagen, Inc. (The Woodlands, TX). Appl. No.: 431,145 Filed: Apr. 28, 1995 I'm sure Bill will deny and/or obfuscate these facts - he's a very sick man - pathological liar.

To: Bill Wexler who wrote (5537)	3/26/1998 12:16:00 AM
From: BDR	Read Replies (1) \| Respond to of 18691

Re: ZONA patent I tried to look up the patent number provided on the ZONA thread using the IBM Patent Server but it was not listed. The press release says that the patent was issued on March 24 and the Patent Server is only updated to March 17. If there is a more current source, someone let us know. I'd like to read the original filing and not the company press release considering the BS they spread around about their other patent (the Zorgniotti patent).